New incident report
Incident Report Number: 2016-2723
Registrant Reference Number: 2016KP041
Registrant Name (Full Legal Name no abbreviations): Bayer Inc
Address: 2920 matheson BLVD
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L4W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-133
Product Name: K9advantixII medium dog
Liquid
Yes
Units: mL
Site: Animal / Usage sur un animal domestique
Other
Dog / Chien
Pekingese
1
Male
14
14
lbs
Skin
>1 wk <=1 mo / > 1 sem < = 1 mois
Unknown / Inconnu
System
Unknown / Inconnu
Yes
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unspecified date in 2011, the canine was switched to K9 Advantix II Medium Dog (Imidacloprid-Permethrin-Pyriproxyfen) topically by the owner. The owner continued to apply the product monthly on approximately the last day of each month. On an unspecified date in 2014, the canine was administered 1 tube of K9 Advantix II Medium Dog (Imidacloprid-Permethrin-Pyriproxyfen) topically by the owner. On an unspecified date 2014, the canine, at approximately 15 years of age, was diagnosed with retinal atrophy by a veterinarian and began to have intermittent episodes of whole body stiffening. No known treatments were performed. On approximately 30Mar2015, the canine was administered 1 tube of K9 Advantix II Medium Dog (Imidacloprid-Permethrin-Pyriproxyfen) topically by the owner. On an unspecified date in Apr2015, the canine was examined and diagnosed with a heart murmur and congestive heart failure. He was referred to a cardiologist. The canine died at home before the cardiologist was consulted. No known necropsy examination was performed. No further information is expected. This case is closed.
Death
Reported signs are not expected as they are inconsistent with pharmaco-toxicological product profile. Death likely consequence of reported signs. Time to onset after Advantix application extremely long (over 3 years). Long time for reporting (over 8 months after death) as the intent of the phone call to Bayer was to ask if the product could be used on another pet, and not to report this adverse event. Other causes are more probable, e.g. geriatric status of the dog. Despite no necropsy was performed, considering exceptionally long time to onset, a product connection is deemed to be unlikely.